Table 1.
Summary of included articles and representation of themes involvedc
| Reference | Study design | Study characteristics | Themes and categories | ||||
|---|---|---|---|---|---|---|---|
| MDTM characteristics and logisticsa | Team culture | Decision makingb | Education | Evaluation and data collection | |||
| Bate J. et al., 2019 [19] | Qualitative study |
Type of MDTM: Ewing sarcoma (ES) Data collection method: survey and focus group N = 15 survey responders and 10 focus group participants of ES patients Period: October 2016 – January 2017 Country: United Kingdom |
* I |
||||
| Bohmeier B. et al., 2021 [20] | Qualitative study |
Type of MDTM: breast cancer, gynaecological cancer Data collection method: semi-structured interviews N = 30 interviews to MDT-members (RR 28%) Period: June 2017 – May 2020 Country: Germany |
* E |
* HI |
|||
| Bolle S. et al., 2019 [21] | Prospective observational study |
Type of MDTM: colorectal cancer Data collection method: MDTM observation N = 741 patient cases in 30 MDTMs observed Period: - Country: The Netherlands |
* HI |
||||
| Butow P. et al., 2007 [22] | Qualitative study |
Type of MDTM: breast cancer Data collection method: survey N = 640 surveys to surgeons, nurses, patient advocates (RR 78%) Period: - Country: Australia |
* E |
||||
| Chaillou D. et al., 2019 [23] | Qualitative study |
Type of MDTM: head and neck cancer Data collection method: survey N = 3 surveys in 54 patients (RR 63%) Period: December 2016 – March 2017 Country: France |
* E |
||||
| Choy E. et al., 2007 [24] | Qualitative study |
Type of MDTM: breast cancer Data collection method: survey and interviews N = 30 patients participated at MDTM N = 17 participating health professionals Period: 2006 Australia |
* I |
||||
| Davison A. et al., 2004 [25] | Retrospective observational study |
Type of MDTM: lung cancer Data collection method: analyse database N = 28 telemedicine MDTMs N = 62 patients Period: November 2000 – November 2001 Country: United Kingdom |
* B |
||||
| Delaney G. et al., 2004 [26] | Observational study |
Type of MDTM: breast cancer Data collection method: N = 27 breast cancer specialists; survey before (RR 59%) and after (RR 62%) start videoconferencing Period: February 2000 – June 2000 Country: Australia |
* B |
* | |||
| Devitt B. et al., 2010 [27] | Qualitative study |
Type of MDTM: not specified Data collection method: focus groups N = 4 focus groups, in total 23 MDT-members Period: - Country: Australia |
* E |
* |
* H |
* | |
| Dew K. et al., 2015 [12] | Prospective observational study + qualitative study |
Type of MDTM: breast cancer, lung cancer, upper-gastro-intestinal cancers, colorectal cancer Data collection method: MDTM recording and content analysis N = 10 MDTMs audio recorded, 106 patients discussed Period: - Country: New Zealand |
* H |
||||
| Díez J. et al., 2019 [28] | Qualitative study |
Type of MDTM: all Data collection method: survey N = 71 MDTM leaders Period: February 2017 – February 2018 Country: Spain |
* | ||||
| Evans L. et al., 2019 [29] | Qualitative study |
Type of MDTM: all Data collection method: Survey and self-assessment N = 180 surveys / 19 MDTs (1stcycle), 118 surveys / 12 MDTs (2nd cycle) completed a self-assessment matrix Period: 2017 and 2018 Country: Australia |
* | ||||
| Evans L. et al., 2021 [30] | Qualitative study |
Type of MDTM: all Data collection method: Survey and self-assessment N = 121 surveys (1stcycle, RR 52%), 118 surveys (2nd cycle, RR 52%), 146 surveys (3rd cycle, RR 65%) completed a self-assessment matrix Period: 2017, 2018, 2019 Country: Australia |
* | ||||
| Fahim C. et al., 2020 [31] | Qualitative study |
Type of MDTM: all Data collection method: Interviews and focus groups N = 21 interviews with MDT-members N = 18 focus group participants (MDT-members) Period: April 2016 – July 2017 Country: Canada |
* ABCDG |
* |
* H |
* | |
| Fahim C. et al., 2020 [32] | Prospective observational study |
Type of MDTM: all Implementation of ‘Knowledge Training strategy’ Data collection method: MDTM observation N = 143 cases / 23 MDTMs (before phase) and 260 cases / 35 MDTMs (after phase) Period: - Country: Canada |
* H |
* | |||
| Farrugia D. et al., 2015 [33] | Retrospective observational study |
Type of MDTM: breast cancer Data collection method: analyse database RQRS = Rapid quality reporting system = web-based standardized documentation template based on national guidelines N = 140 patients in cohort of 10 weeks before start RQRS N = 142 patients in cohort 10 weeks after start RQRS Period: July – October 2013 Country: United States of America |
* G |
||||
| Field K. et al., 2010 [34] | Qualitative study |
Type of MDTM: neuro-oncology Data collection method: survey N = 16 MDT-members (RR 100%) Period: July 2009 Country: Australia |
* FG |
||||
| Gandamihardja T. et al., 2019 [35] | Prospective observational study |
Type of MDTM: breast cancer Data collection method: MDTM observation N = 346 cases Period:- Country: United Kingdom |
* F |
* | * | ||
| Gatcliffe T. et al., 2008 [36] | Prospective observational study |
Type of MDTM: gynaecological Data collection method: MDTM recording N = 52 MDTMs Period: May 2002 – August 2003 Country: United States of America |
* | ||||
| Hahlweg P. et al., 2015 [37] | Prospective observational study and qualitative study |
Type of MDTM: all Data collection method: MDTM observation and content analysis and descriptive statistics N = 15 MDTMs observed Period: November – December 2013 Country: Germany |
* G |
* HI |
* | ||
| Hahlweg P. et al., 2017 [38] | Cross-sectional observational study |
Type of MDTM: all Data collection method: MDTM observation N = 249 cases, 29 MDTMs Period: - Country: Germany |
* I |
||||
| Hamilton D. et al., 2016 [39] | Prospective observational study + qualitative study |
Type of MDTM: head and neck cancers Data collection method: MDTM observation and ethnographic analyses N = 35 MDTMs and 37 MDT clinics observed; audio recorded and transcribed verbatim N = semi structured interviews with 20 patients and 9 MDTM staff members Period: - Country: United Kingdom |
* I |
||||
| Harris J. et al., 2014 [40] | Prospective observational study + qualitative study |
Type of MDTM: all Data collection method: MDTM observation and interviews N = 20 MDTMs observed N = 64 team members, 19 peer observers interviews Period: - Country: United Kingdom |
* | ||||
| Harris J. et al., 2016 [41] | Prospective observational study |
Type of MDTM: all Data collection method: MDTM observation N = 10 MDTMs, 13 health service staff observers, 1 clinical and 1 non-clinical observer Period: - Country: United Kingdom |
* | ||||
| Hoinvile L. et al., 2019 [42] | Qualitative study |
Type of MDTM: all Data collection method: survey N = 1220 MDT-members Period: March – May 2017 Country: United Kingdom |
* F |
||||
| Huizen van S., et al. 2019 [43] | Prospective observational study + qualitative study |
Type of MDTM: head and neck cancer Data collection method: MDTM observation and semi-structured interviews N = 6 interviews to MDT-members, N = 336 cases observed Period: - Country: The Netherlands |
* F |
||||
| Jalil R. et al., 2012 [44] | Qualitative study |
Type of MDTM: all Data collection method: survey N = 265 MDT-coordinators Period: - Country: United Kingdom |
* G |
||||
| Jalil R. et al., 2013 [45] | Qualitative study |
Type of MDTM: urology and gastroenterology Data collection method: interviews N = 22 MDTM members Period: - Country: United Kingdom |
* BCE |
* |
* HI |
||
| Jalil R. et al., 2014 [46] | Prospective observational study |
Type of MDTM: urology Data collection method: MDTM observation N = 683 case discussions, 127 video recorded case discussions Period: - Country: United Kingdom |
* | ||||
| Janssen A. et al., 2018 [47] | Prospective observational study + qualitative study |
Type of MDTM: all Data collection method: MDTM observation and semi-structured interviews N = 7 teams, 43 MDTMS N = 15 interviews Period: - Country: Australia |
* BCG |
* H |
* | * | |
| Jenkins V. et al., 2001 [48] | Qualitative study |
Type of MDTM: breast cancer Data collection method: survey N = 64 MDT-members (RR 91%) Period: - Country: United Kingdom |
* |
* H |
|||
| Johnson C. et al., 2017 [49] | Qualitative study |
Type of MDTM: All Data collection method: survey N = 3 MDTMs Period: - Country: Australia |
* | ||||
| Kunkler I. et al., 2006 [50] | Qualitative study |
Type of MDTM: breast cancer Data collection method: survey N = 68 participants to Group behavior Inventory (GBI) survey: face-to-face GBI (RR 65%), post telemedicine GBI (RR 51%) Period: - Country: United Kingdom |
* | *H | |||
| Lamb B. et al., 2011 [51] | Qualitative study |
Type of MDTM: all Data collection method: Semi-structured interviews N = 19 interviews with clinicians Period: October 2009 – April 2010 Country: United Kingdom |
*ABCD | * | |||
| Lamb B. et al., 2011 [52] | Prospective observational study + qualitative study |
Type of MDTM: all Data collection method: MDTM observation and survey N = 164 cases observed, 67 surveys to MDT-members (RR 70%) Period: September – November 2009 Country: United Kingdom |
* H |
* | |||
| Lamb B. et al., 2012 [53] | Qualitative study |
Type of MDTM: All Data collection method: Survey N = 175 MDTM members Period: October 2010 – April 2011 Country: United Kingdom |
* B |
* H |
|||
| Lamb B. et al., 2013 [54] | Longitudinal observational study |
Type of MDTM: urology Data collection method: N = 36 MDTMs, 1421 patients Multicomponent intervention: MDTM checklists before start, team training and written guidance Period: December 2009 – April 2011 Country: United Kingdom |
* BC |
* H |
|||
| Lamb B. et al., 2013 [55] | Prospective observational study |
Type of MDTM: urology Data collection method: MDTM observation N = 7 MDTMs, assessing 298 cases Period: December 2009 – January 2010 Country: United Kingdom |
* CDF |
* H |
|||
| Lamb B. et al., 2013 [56] | Qualitative study |
Type of MDTM: all Data collection method: survey N = 1636 surveys to MDT-members (RR 80%) Period: 2009 Country: United Kingdom |
* AC |
* I |
|||
| Lee Y. et al., 2017 [57] | Qualitative study |
Type of MDTM: all Data collection method: survey N = 1000 MDT-members (RR 18%) Period:- Country: Korea |
* D |
* HI |
|||
| Lumenta D. et al., 2019 [58] | Observational Prospective observational study |
Type of MDTM: all Data collection method: MDTM observation N = 27 MDTMs, 244 patients discussed Period: - Country: United Kingdom |
* | ||||
| Makaskill E. et al., 2006 [59] | Qualitative study |
Type of MDTM: breast cancer Data collection method: survey N = 250 surveys to surgeons (RR 61%) Period: - Country: United Kingdom |
* ACDFG |
* | |||
| Massoubre J. et al., 2018 [60] | Prospective observational study |
Type of MDTM: head and neck cancer Data collection method: MDTM observation N = 119 patients Period: May – November 2014 Country: France |
* E |
||||
| Mullan B. et al., 2014 [61] | Prospective observational Study |
Type of MDTM: head and neck cancer Data collection method: MDTM observation N = 10 MDTMs, N = 105 patients Period: January – September 2011 Country: United Kingdom |
* F |
||||
| Neri E. et al., 2021 [62] | Qualitative study |
Type of MDTM: all Data collection method: survey N = 292 radiologists Period: 2018 Country: Germany |
* C |
||||
| Oeser A. et al., 2018 [63] | Qualitative study |
Type of MDTM: head and neck cancer Data collection method: survey N = 8 clinical experts Period: - Country: Germany |
* C |
* H |
|||
| Ottevanger N. et al., 2013 [64] | Prospective observational study + qualitative study |
Type of MDTM: all Data collection method: MDTM observation ans interviews N = 18 MDTMs, 15 chairs interviewed Period: January 2010 – April 2011 Country: The Netherlands |
* ABCDG |
||||
| Patkar V. et al., 2012 [65] | Qualitative study |
Type of MDTM: breast cancer Data collection method: survey N = 1295 cases, 48 surveys (RR 89%) Period: - Country: United Kingdom |
* H |
* | |||
| Pype P. et al., 2017 [66] | Qualitative study |
Type of MDTM: all Data collection method: Semi-structured interviews N = 16 interviews with general practitioners Period: May–June 2014 Country: Belgium |
* D |
* H |
|||
| Rajasekaran R. et al., 2021 [67] | Qualitative study |
Type of MDTM: sarcoma Data collection method: survey N = 39 MDT-members (RR 92%) Period: May 2020 Country: United Kingdom |
* B |
||||
| Rankin N. et al., 2017 [68] | Qualitative study |
Type of MDTM: lung cancer Data collection method: survey N = 41 participants for documentation template development and implementation N = 492 surveys to general practitioners (RR 12%) |
* G |
||||
| Rankin N. et al., 2018 [69] | Qualitative study |
Type of MDTM: lung cancer Data collection method: structured interviews and survey N = 492 surveys (RR 12%), 35 interviews with general practitioners Period: May 2014- May 2015 Country: Australia |
* D |
||||
| Robinson T. et al., 2017 [70] | Prospective observational study + qualitative study |
Type of MDTM: all Data collection method: MDTM observation and semi-structured interviews N = 43 MDTMs observed, 18 interviews Period: 2013 Country: Australia |
* CG |
* H |
* | ||
| Rosell L. et al., 2018 [71] | Qualitative study |
Type of MDTM: all Data collection method: survey N = participants of 50 MDTMs, 362 surveys (RR 67%) Period: - Country: Sweden |
* C |
* HI |
|||
| Salami A. et al., 2015 [72] | Retrospective cohort study |
Type of MDTM: hepatocellular carcinoma Data collection method: analyse database N = 116 patients in total. N = 48 patients discussed through virtual MDTM |
* B |
||||
| Salloch S. et al., 2014 [73] | Prospective observational study + qualitative study |
Type of MDTM: all Data collection method: MDTM observation N = 14 MDTMs, 136 cases Period: - Country: Germany |
* I |
||||
| Sarkar S. et al., 2014 [74] | Qualitative study |
Type of MDTM: urological cancers Data collection method: Semi-structured interview N = 20 MDT-members Period: - Country: United Kingdom |
* BC |
* HI |
|||
| Scot R. et a, 2020 [75] | Cross-sectional observational study |
Type of MDTM: gynaecological cancers Data collection method: MDTM observation N = 41 MDT case discussions Period: 6th – 29th March 2019 Country: United Kingdom |
* I |
* | * | ||
| Shah S. et al., 2014 [76] | Prospective observational study |
Type of MDTM: colorectal cancer Data collection method: N = 267 cases Period: - Country: United Kingdom |
* | ||||
| Snyder J. et al., 2017 [77] | Qualitative study |
Type of MDTM: neuro-oncology Data collection method: survey N = 85 surveys to MDTM-chairs (RR 54%) Period: November 2015 – February 2016 Country: United States of America |
* BD |
* H |
* | ||
| Soukup T. et al., 2016 [78] | Cross-sectional observational study |
Type of MDTM: breast cancer, lung cancer, colorectal cancer, urological cancers Data collection method: MDTM observation N = 1045 cases Period: 2010–2014 Country: United Kingdom |
* C |
||||
| Soukup T. et al., 2016 [79] | Prospective observational study |
Type of MDTM: breast cancer, lung cancer, colorectal cancer, urological cancers Data collection method: MDTM observation N = 1045 cases Period: 2010–2014 Country: United Kingdom |
* HI |
||||
| Soukup T. et al., 2019 [80] | Longitudinal observational study |
Type of MDTM: breast cancer Data collection method: MDTM observation N = 1355 cases reviewed Period: 2013 – 2015 Country: United Kingdom |
* H |
||||
| Soukup T. et al., 2020 [81] | Cross-sectional observational study |
Type of MDTM: breast cancer, gynaecological cancers, colorectal cancer Data collection method: MDTM observation N = 30 MDTMs, 822 cases discussions, 44 MDT-members Period: September 2015 – July 2016 Country: United Kingdom |
* H |
||||
| Stone E. et al., 2018 [82] | Qualitative study |
Type of MDTM: lung cancer Data collection method: survey + consensus conference (Delphi process) N = 350 survey’s round 1 (RR 35%), 98 surveys round 2 (RR 53%), 14 participants for consensus conference on MDTM dataset Period: - Country: Australia |
* B |
* H |
|||
| Stone E. et al., 2020 [83] | Qualitative study |
Type of MDTM: lung cancer Data collection method: survey and interviews N = survey 1; 18 MDT-members, survey 2; 25 MDT-members, 6 semi-structured interviews Period: - Country: Australia |
* | ||||
| Taylor C. et al., 2012 [84] | Prospective observational study |
Type of MDTM: colon cancer Data collection method: MDTM observation N = 10 MDTMs Period:- Country: United Kingdom |
* | ||||
| Taylor C. et al., 2012 [85] | Qualitative study |
Type of MDTM: all Data collection method: survey N = 637 MDT-members (RR 52%) Period: - Country: United Kingdom |
* | ||||
| Taylor C. et al., 2021 [86] | Qualitative study |
Type of MDTM: breast cancer Data collection method: interviews N = 36 interviews, 10 MDTMs Period: 2014 Country: United Kingdom |
* | ||||
| Vetto J. et al., 1996 [87] | Qualitative study |
Type of MDTM: all Data collection method: survey N = 22 MDT-members (RR 100%) Period: 1990 – 1991 and 1992–1993 Country: United States of America |
* F |
||||
| Wallace I. et al., 2019 [88] | Prospective observational study + Qualitative study |
Type of MDTM: gynaecological cancers, hematological cancers, skin cancers Data collection method: MDTM observation and thematic analysis of cases N = 122 MDTMs, 58 cases Period: - Country: United Kingdom |
* H |
||||
| Wihl J. et al., 2021 [89] | Prospective observational study |
Type of MDTM: sarcoma, hepato-biliary cancer, neuro-oncology cancers Data collection method: MDTM observation N = 336 cases, 3 MDTMs Period: April 2019 – October 2019 Country: Sweden |
* C |
* I |
|||
| Wright F. et al., 2009 [90] | Qualitative study |
Type of MDTM: all Data collection method: survey N = 385 MDT-members (RR 44%) Period: March 2007 – May 2007 Country: Canada |
* D |
||||
| Yuan Y. et al., 2018 [91] | Retrospective observational study |
Type of MDTM: gastro intestinal cancers Data collection method: analyse database N = 3674 patients discussed in MDTMs Period: January 2015 – December 2016 Country: China |
* BF |
* H |
|||
aThe theme of MDTM characteristics and logistics was divided into 7 categories: A = Schedule, B = Meeting discipline and circumstances, C = Preparation, D = Attendance, E = Patients attending MDTMs, F = Cases and streamlining, G = administrative support
bThe Theme of decision making was divided into 2 categories: H = Decision making process and I = patient advocacy
cAbbreviations: MDTM multidisciplinary team meeting, RR response rate